| Entry |
|
|---|
| Name |
Methandriol dipropionate;
Anadiol (TN) |
|---|
| Formula |
C26H40O4
|
|---|
| Exact mass |
416.2927
|
|---|
| Mol weight |
416.5934
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
|
|---|
| Remark |
|
|---|
| Efficacy |
Anabolic, Androgen receptor agonist |
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
DG01276 Methandriol
D08197 Methandriol dipropionate
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C4 (AR)
D08197 Methandriol dipropionate
Drug groups [BR:br08330]
Hormonal agent
DG01590 Androgen receptor agonist
DG01605 Anabolic steroid
DG01276 Methandriol
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 30
1 C1x C 21.2407 -19.9782
2 C1y C 21.2407 -21.3803
3 C1x C 22.3623 -22.0112
4 C2y C 23.5541 -21.3803
5 C1z C 23.5541 -19.9782
6 C1x C 22.3623 -19.3472
7 C2x C 24.7459 -22.0112
8 C1x C 25.9377 -21.3803
9 C1y C 25.9377 -19.9782
10 C1y C 24.7459 -19.3472
11 C1y C 27.1294 -19.3472
12 C1z C 27.1294 -17.9451
13 C1x C 25.9377 -17.2441
14 C1x C 24.7459 -17.9451
15 C1x C 29.5130 -19.3472
16 C1x C 29.5130 -17.9451
17 C1z C 28.3212 -17.2441
18 C1a C 27.1294 -16.6132
19 O7a O 28.3212 -15.9121
20 O7a O 19.9788 -22.0813
21 C1a C 29.6532 -16.8936
22 C1a C 23.5541 -18.5761
23 C7a C 18.7763 -21.3603
24 C1b C 17.5506 -22.0412
25 O6a O 18.7992 -19.9783
26 C7a C 28.3212 -14.5100
27 C1b C 29.5354 -13.8090
28 C1a C 30.7327 -14.5004
29 O6a O 27.1070 -13.8090
30 C1a C 16.3680 -21.3321
BOND 33
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 2
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 12 18 1 #Up
22 17 19 1 #Up
23 2 20 1 #Up
24 17 21 1 #Down
25 5 22 1 #Up
26 20 23 1
27 23 24 1
28 23 25 2
29 19 26 1
30 26 27 1
31 27 28 1
32 26 29 2
33 24 30 1
|
|---|
